CytoDyn Inc lands $28.5M convertible note financing to fund leronlimab advancement
CytoDyn Inc (OTCQB:CYDY) has secured $25 million in immediately available capital thanks to a $28.5 million non-dilutive convertible debt offering with an institutional investor, the company announced Thursday.
The note has a two-year maturity, bears interest at 10% annually and is secured by the company’s assets, save its intellectual property. The note can be converted into CytoDyn stock at a price of $10 per share.
“We are very pleased with the continued support and tremendous confidence demonstrated by this institution’s fourth financing round with us,” CytoDyn CEO Nader Pourhassan said in a statement. “They clearly understand the opportunity before us and we now have the liquidity to accelerate our business plan without tapping into the increased share authorization recently approved by our stockholders.”
READ: CytoDyn claims promising safety data from Phase 2 coronavirus trial of its drug leronlimab
CytoDyn plans to use the funds to advance its lead drug leronlimab, which has shown multiple potential indications, including as a treatment for the coronavirus (COVID-19).
The company met the 75-patient enrollment target for its Phase 2 coronavirus trial, a randomized clinical trial for patients with mild-to-moderate coronavirus symptoms, and enrollment continues in its Phase 2b/3 clinical trial for severe and critically ill coronavirus patients.
“This injection of capital will help us deliver leronlimab to patients as soon as the regulatory pathway is clear for potentially Covid-19 (for three different populations), cancer (23 different indications), and HIV (combination, monotherapy, HIV cure and PrEP),” Pourhassan said.
“I am very excited to share with all of our stakeholders the excitement we have around our Covid-19 therapies during tomorrow’s conference call, as well as our expected timelines.”
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/925476/cytodyn-inc-lands-285m-convertible-note-financing-to-fund-leronlimab-advancement-925476.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).